Evaluating Residual Congestion at Discharge in Acute Heart Failure Patients
Recruiting
Observational Study
Acute Heart Failure (AHF)
Congestive Heart Failure(CHF)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Consorci Sanitari Integral · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Treatment of congestion is one of the main goals in patients hospitalized for acute heart failure. Nevertheless, current evidence shows that decongestion is often not achieved and that residual congestion at discharge is strongly associated with poor outcomes. While this association has been demonstrated, previous studies have primarily focused on single parameters of congestion (physical examinat…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years.
* Patients hospitalized for new onset heart failure or worsening heart failure defined by:
1. Symptoms classified as New York Heart Association class III or IV.
2. Clinical or instrumental signs of volume overload (e.g., dyspnea with evidence of pulmonary …
Contacts